Fidelity SPDR Advertisement
Home > Boards > US Listed > Biotechs > Arena Pharmaceuticals, Inc. (ARNA)

Keep In This in Mind....

Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (2) | Next 10 | Previous | Next
centurycom Member Profile
 
Followed By 8
Posts 1,652
Boards Moderated 0
Alias Born 12/17/04
160x600 placeholder
Arena Pharmaceuticals Issued Composition of Matter Patent by United States Patent and Trademark Office for Ralinepag and Rela... "PR Newswire (US)" - 11/25/2014 8:00:00 AM
Arena Pharmaceuticals to Present at Piper Jaffray 26th Annual Healthcare Conference "PR Newswire (US)" - 11/24/2014 8:00:00 AM
Arena Pharmaceuticals to Present at Stifel 2014 Healthcare Conference "PR Newswire (US)" - 11/13/2014 8:00:00 AM
Quarterly Report (10-q) "Edgar (US Regulatory)" - 11/6/2014 4:57:53 PM
Lorcaserin HCl Data to be Presented at the Annual Meeting of the American Association for the Study of Liver Diseases "PR Newswire (US)" - 11/6/2014 8:00:00 AM
Arena Pharmaceuticals to Present at Credit Suisse 2014 Healthcare Conference "PR Newswire (US)" - 11/5/2014 8:00:00 AM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 11/3/2014 7:31:36 AM
Arena Pharmaceuticals Provides Corporate Update and Reports Third Quarter 2014 Financial Results "PR Newswire (US)" - 11/3/2014 6:45:00 AM
Eisai and Arena Pharmaceuticals Report Results of an Investigational Phase 2 Trial of Lorcaserin HCl as an Aid for Smoking Ce... "PR Newswire (US)" - 11/3/2014 6:30:00 AM
Lorcaserin Data to be Presented at The Obesity Society's Annual Scientific Meeting "PR Newswire (US)" - 10/31/2014 8:37:00 AM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 10/30/2014 9:19:06 AM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 10/30/2014 6:03:00 AM
Eisai and Arena Pharmaceuticals Report Results of an Investigational Pilot Study of Coadministration of Lorcaserin HCl and Ph... "PR Newswire (US)" - 10/28/2014 6:20:00 PM
Arena Pharmaceuticals Announces Third Quarter 2014 Conference Call and Webcast on Monday, November 3 "PR Newswire (US)" - 10/27/2014 8:00:00 AM
Eisai and Arena Pharmaceuticals Announce Presentation of Lorcaserin HCl Data at the American College of Clinical Pharmacy Ann... "PR Newswire (US)" - 10/13/2014 8:00:00 AM
Eisai and Arena Pharmaceuticals Announce Publication of Pooled Phase 3 Clinical Trial Analysis of BELVIQ® (lorcaserin HCl) C... "PR Newswire (US)" - 10/10/2014 11:36:00 AM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 10/9/2014 4:41:48 PM
Arena Pharmaceuticals to Present at the NewsMakers in the Biotech Industry Conference "PR Newswire (US)" - 9/22/2014 8:00:00 AM
Statement of Changes in Beneficial Ownership (4) "Edgar (US Regulatory)" - 9/19/2014 4:49:54 PM
FDA Approves Orexigen's Diet Drug Contrave "Dow Jones News" - 9/11/2014 8:50:11 AM
Lorcaserin HCl Data to be Presented at the American Society of Bariatric Physicians' 64th Annual Obesity & Associated Conditi... "PR Newswire (US)" - 9/10/2014 8:00:00 AM
Arena Pharmaceuticals' APD811 Granted Orphan Drug Status for Pulmonary Arterial Hypertension "PR Newswire (US)" - 9/2/2014 8:00:00 AM
Statement of Changes in Beneficial Ownership (4) "Edgar (US Regulatory)" - 8/27/2014 7:52:46 PM
Quarterly Report (10-q) "Edgar (US Regulatory)" - 8/6/2014 4:34:28 PM
centurycom   Saturday, 06/29/13 08:47:09 AM
Re: None
Post # of 21626 
Keep In This in Mind....

From Mötley:

"If obesity gains acceptance as a disease, it could open the doors for significant new spending on treatments. Is a payday on the way for some companies helping to fight America's new epidemic disease?

Echo effect
Before we get ahead of ourselves, keep in mind that the AMA's decision doesn't mean much on its own. No insurance company or governmental agency is obligated to begin paying for additional treatments just because the AMA now calls obesity a disease.

However, as the largest organization in the nation representing physicians, the AMA carries considerable weight (no pun intended). Already, other influential parties are echoing the decision made by the AMA.

For example, Sens. Tom Carper and Lisa Murkowski and Reps. Bill Cassidy and Ron Kind jointly wrote an op-ed piece in the New York Times commending the AMA's action. The legislators have introduced a bill in both chambers of Congress to allow Medicare to reimburse for obesity drugs and promote intensive behavioral counseling for obesity. This bill is bipartisan. Carper and Cassidy are Democrats, while Murkowski and Kind are Republicans"

-------------------------
And Remember, It was Congress who requested the HHS , and FDA do something about the obesity epidemic,before Bellviq was approved, so it is highly likely that there has been a plan all along to make obesity a disease.

Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (2) | Next 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist